Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review

Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review

Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. It is effective against many bacteria-producing carbapenemases or other specific hydrolases. This scoping review aims to define the role acquired by plazomicin fr...

Full description

Bibliographic Details
Main Authors:	Aniello Alfieri, Sveva Di Franco, Valerio Donatiello, Vincenzo Maffei, Ciro Fittipaldi, Marco Fiore, Francesco Coppolino, Pasquale Sansone, Maria Caterina Pace, Maria Beatrice Passavanti
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Life
Subjects:	antimicrobial resistance bloodstream infections multi-resistant <i>Enterobacterales</i> pyelonephritis plazomicin scoping review
Online Access:	https://www.mdpi.com/2075-1729/12/12/1949

Similar Items

Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions
by: David Ngo, et al.
Published: (2023-02-01)

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
by: Irene Galani, et al.
Published: (2019-02-01)

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2019-03-01)

A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients
by: Sveva Di Franco, et al.
Published: (2022-10-01)

Blood Stream Infections from MDR Bacteria
by: Sveva Di Franco, et al.
Published: (2021-06-01)

Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
by: María-José Valderrama, et al.
Published: (2020-08-01)

Updates on the Virulence Factors Produced by Multidrug-Resistant <i>Enterobacterales</i> and Strategies to Control Their Infections
by: Mohd W. Azam, et al.
Published: (2023-07-01)

Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis
by: Yan Chen, et al.
Published: (2022-04-01)

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji
by: Michael J. Loftus, et al.
Published: (2022-09-01)

Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients
by: Núria Sabé, et al.
Published: (2022-06-01)

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome
by: Mladen Pospišil, et al.
Published: (2023-09-01)

Enterobacterales plasmid sharing amongst human bloodstream infections, livestock, wastewater, and waterway niches in Oxfordshire, UK
by: William Matlock, et al.
Published: (2023-03-01)

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
by: Wei Yu, et al.
Published: (2021-11-01)

Co-Lateral Effect of Octenidine, Chlorhexidine and Colistin Selective Pressures on Four Enterobacterial Species: A Comparative Genomic Analysis
by: Mathilde Lescat, et al.
Published: (2021-12-01)

The Impact of COVID-19 Pandemic on ESBL-Producing <i>Enterobacterales</i> Infections: A Scoping Review
by: Ha Thi Thao Mai, et al.
Published: (2023-06-01)

Emerging Threat of Multidrug Resistant Pathogens From Neonatal Sepsis
by: Hua Zou, et al.
Published: (2021-07-01)

Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients
by: Nasreen Hassoun-Kheir, et al.
Published: (2023-11-01)

Bloodstream Infections by <i>Pantoea</i> Species: Clinical and Microbiological Findings from a Retrospective Study, Italy, 2018–2023
by: Roberto Casale, et al.
Published: (2023-12-01)

Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamase Producing <i>Enterobacterales</i> in Healthy Community Dogs in Israel
by: Anat Shnaiderman-Torban, et al.
Published: (2022-08-01)

Characteristics of Extended-Spectrum β-Lactamase Producing Enterobacterales Isolated from Dogs and Cats, 2011–2021
by: Dennis J. Woerde, et al.
Published: (2023-02-01)

Risk Factors for Community-Acquired Urinary Tract Infections Caused by Multidrug-Resistant Enterobacterales in Thailand
by: Kanit Assawatheptawee, et al.
Published: (2022-08-01)

Colonization and Healthcare-Associated Infection of Carbapenem-Resistant <i>Enterobacteriaceae</i>, Data from Polish Hospital with High Incidence of Carbapenem-Resistant <i>Enterobacteriaceae,</i> Does Active Target Screening Matter?
by: Iwona Pawłowska, et al.
Published: (2023-02-01)

Duration of carriage of multidrug resistant Enterobacterales in discharged hospital and general practice patients and factors associated with clearance
by: Celine van Weerlee, et al.
Published: (2020-09-01)

Detection of Carbapenem-Resistant Enterobacterales in Simulated Blood Culture in 15 Minutes
by: Daria Baer, et al.
Published: (2021-02-01)

Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing <i>Enterobacterales</i> Infections
by: Corneliu Ovidiu Vrancianu, et al.
Published: (2021-03-01)

Opioid sparing effect of intravenous dexmedetomidine in orthopaedic surgery: a retrospective analysis
by: Valerio Donatiello, et al.
Published: (2022-12-01)

Wild-Type AmpC Beta-Lactamase-Producing <i>Enterobacterales</i> Are a Risk Factor for Empirical Treatment Failure in Patients with Bloodstream Infection
by: Matteo Vassallo, et al.
Published: (2024-03-01)

Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update
by: M Lowe, et al.
Published: (2022-08-01)

Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance
by: Anna Duda-Madej, et al.
Published: (2023-11-01)

Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms
by: Bekana K. Tadese, et al.
Published: (2022-12-01)

Antibiotic-Resistant Bacteria across a Wastewater Treatment Plant
by: Ofélia Godinho, et al.
Published: (2024-02-01)

Estimation, Evaluation and Characterization of Carbapenem Resistance Burden from a Tertiary Care Hospital, Pakistan
by: Aamir Jamal Gondal, et al.
Published: (2023-03-01)

Analysis of Antimicrobial Resistance Genes (ARGs) in Enterobacterales and <i>A. baumannii</i> Clinical Strains Colonizing a Single Italian Patient
by: Alessandra Piccirilli, et al.
Published: (2023-02-01)

Whole-Genome Sequencing and Molecular Analysis of Ceftazidime–Avibactam-Resistant KPC-Producing <i>Klebsiella pneumoniae</i> from Intestinal Colonization in Elderly Patients
by: Giulia Errico, et al.
Published: (2023-08-01)

Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences
by: Marianna Criscuolo, et al.
Published: (2020-02-01)

Highly Virulent and Multidrug-Resistant <i>Escherichia coli</i> Sequence Type 58 from a Sausage in Germany
by: Elias Eger, et al.
Published: (2022-07-01)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
by: Giacobbe DR, et al.
Published: (2020-12-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
by: Chun-Fu Huang, et al.
Published: (2023-04-01)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
by: Francisco Montiel-Riquelme, et al.
Published: (2020-10-01)

Mother-to-Neonate Transmission of Antibiotic-Resistant Bacteria: A Cross-Sectional Study
by: Lital Ashtamkar Matok, et al.
Published: (2021-06-01)